Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.

Relmada Therapeutics (NASDAQ:RLMD) outlined progress on its lead urology oncology program and reviewed fourth-quarter results during its fourth quarter and full year 2025 earnings call, highlighting ...

BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart failure, yet no pharmacological therapy is approved for PAC suppression.

Shenouda With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, ...

Doulas provide emotional, physical, and informational support during pregnancy, labor, and the postpartum period.

Marketers are projected to have invested nearly $400 billion in US media in 2025, based on estimates from MAGNA and eMarketer. About half of that will go toward finding new customers. Yet, as ...

Eighteenth-­century mental institutions employed a tactic called the bain de surprise, suddenly dunking their patients in cold water to jolt them out of their depression or psychosis. (Some doctors ...

(NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA ® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI ® ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the 'Company'), a clinical-stage biopharmaceutical company focused on its Phase ...

Specialization has become both a differentiator and a credibility signal, helping coaches stand out and deliver deeper, more ...

China’s Unitree G1 humanoid robot plays tennis after training on 5 hours of amateur motion capture data from five players.

Throughout the year, the Company reported significant positive preclinical findings for SIL204 across eight KRAS mutations and four cancer types, including first evidence of activity in gastric cancer ...